期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

骨髓增殖性疾病中JAK2V617F突变和PRV-1表达的研究

下载PDF
导出
作者 郭慧梅 潘崚 郭晓玲 张学军 王福旭 董作仁
机构地区 河北医科大学第二医院血液科河北省血液重点实验室
出处 《临床荟萃》 CAS 北大核心 2008年第15期1108-1110,共3页 Clinical Focus
基金 河北省重大基础研究项目(08966107D)
关键词 骨髓增殖性疾病 基因表达 突变
分类号 R733.3 [医药卫生—肿瘤]
  • 相关文献

参考文献16

  • 1Baxter EJ,Scott LM,Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders[J]. Lancet,2005,366(9464) : 1054-1061.
  • 2James C,Ugo V, Le Couedic JP, et al. A unique clonal JAK2 mutation leading to constitutive signalling polycythaemia vera[J]. Nature,2005,434(7037) : 1144-1148.
  • 3Levine RL, Wadleigh M, Cools J, et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis [J]. Cancer Cell, 2005,7 (4) :387-397.
  • 4Kralovics R,Passamonti F, Buser AS, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders[J]. N Engl J Med,2005,352 (17) : 1779-1790.
  • 5Zhao R, Xing S, Li Z, et al. Identification of an acquired JAK2 mutation in Polycythemia vera[J]. J Biol Chem, 2005, 280 (24) : 22788-22792.
  • 6王冬梅,郭慧梅,王菊美,孙国峰,郭晓玲,潘崚.JAK2V617F点突变与BCR-ABL阴性骨髓增殖性疾病临床关系研究[J].临床荟萃,2008,23(5):317-321. 被引量：3
  • 7Steensma DP,Dewald GW, Lasho TL, et al. The JAK2V617F activating tyrosine kinase mutation is an infrequent event in both " atypical " myeloproliferative disorders and myelodysplastic syndromes [J]. Blood, 2005, 106 (4) : 1207- 1209.
  • 8郭慧梅,潘崚,郭晓玲,张学军,王福旭,董作仁.具有JAK2V617F突变的原发性血小板增多症转化为急性髓系白血病1例并文献复习[J].临床荟萃,2008,23(4):289-290. 被引量：2
  • 9Temerinac S,Klippel S, Strunck E, et al. Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera[J]. Blood, 2000,95 (8) :2569-2576.
  • 10Tefferi A, Lasho TL, Wolanskyj AP, et al. Neutrophil PRV-1 mRNA expression across the chronic myeloproliferative disorders and in secondary or spurious polyeythemia[J]. Blood, 2004,103 (9) : 3547-3548.

二级参考文献24

  • 1陈况,黄细莲,钱申贤.原发性血小板增多症转变为急性髓系白血病一例[J].中华内科杂志,2006,45(8):700-700. 被引量：6
  • 2Gangat N, Wolanskyj AP, McClure RF, et al. Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients [J].Leukemia,2007,21(2):270-276.
  • 3张富兰 王继红.原发性血小板增多症转化为嗜碱性粒细胞白血病1例报告.山东医药,2000,40(14):4-4.
  • 4李汉贵.原发性血小板增多症以急淋告终1例.临床血液学杂志,1999,12(2):82-82.
  • 5Baxter EJ, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders[J]. Lancet, 2005,365(9464) : 1054-1061.
  • 6James C,Ugo V, Le Couedic JP, et al. A unique ctonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera[J]. Nature,2005,434(7037) :1144-1148.
  • 7Levine RL, Wadleigh M, Cools J, et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia,and myeloid metaplasia with myelofibrosis [J]. Cancer Cell,2005,7(4) :387-397.
  • 8Kralovics R,Passamonti F, Buser AS, et at. A gain-of-function mutation of JAK2 in myeloproliferative disorders[J].N Engl J Med, 2005,352(17) :1779-1790.
  • 9Rossi D, Deambrogi C,Capello D, et at. JAK2V617F mutation in leukaemic transformation of philadelphia negative chronic myeloproliferative disorders[J].Blood (ASH Annual Meeting Abstracts), 2006,108 : 3605.
  • 10Campbell PJ,Baxter EJ, Beer PA, et al. Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation [J].Blood, 2006, 108(10) :3548-3555.

共引文献3

临床荟萃
2008年 第15期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部